WDNA vs. EKG
WDNA (WisdomTree BioRevolution Fund) and EKG (First Trust Nasdaq Lux Digital Health Solutions ETF) are both Health & Biotech Equities funds - WDNA tracks the WisdomTree BioRevolution Index while EKG tracks the NASDAQ Lux Health Tech Index. Both are passively managed. Over the past 3 years, WDNA returned 3.54%/yr vs 0.16%/yr for EKG. A 0.73 correlation means they provide meaningful diversification when combined. WDNA charges 0.45%/yr vs 0.65%/yr for EKG.
Performance
WDNA vs. EKG - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, WDNA achieves a 8.96% return, which is significantly higher than EKG's -7.15% return.
WDNA
- 1D
- 2.94%
- 1M
- 2.56%
- YTD
- 8.96%
- 6M
- 10.44%
- 1Y
- 50.50%
- 3Y*
- 3.54%
- 5Y*
- -4.78%
- 10Y*
- —
EKG
- 1D
- 3.29%
- 1M
- 6.48%
- YTD
- -7.15%
- 6M
- -10.81%
- 1Y
- 1.80%
- 3Y*
- 0.16%
- 5Y*
- —
- 10Y*
- —
WDNA vs. EKG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
WDNA WisdomTree BioRevolution Fund | 8.96% | 22.68% | -14.18% | -2.07% | -12.71% |
EKG First Trust Nasdaq Lux Digital Health Solutions ETF | -7.15% | 11.89% | 6.53% | -0.11% | -19.59% |
Correlation
The correlation between WDNA and EKG is 0.62, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.62 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.67 |
Correlation (All Time) Calculated using the full available price history since Mar 24, 2022 | 0.73 |
The correlation between WDNA and EKG shifts across timeframes, from 0.62 (1 year) to 0.73 (all time), reflecting how their relationship changes across market environments.
WDNA vs. EKG - Sectors Allocation Comparison
Sectors
WDNA
EKG
Healthcare
Basic Materials
-
Consumer Defensive
-
Energy
-
Communication Services
-
-
Consumer Cyclical
-
-
Financial Services
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
Utilities
-
-
Healthcare
WDNA
EKG
Basic Materials
WDNA
EKG
-
Consumer Defensive
WDNA
EKG
-
Energy
WDNA
EKG
-
Communication Services
WDNA
-
EKG
-
Consumer Cyclical
WDNA
-
EKG
-
Financial Services
WDNA
-
EKG
-
Industrials
WDNA
-
EKG
-
Real Estate
WDNA
-
EKG
-
Technology
WDNA
-
EKG
Utilities
WDNA
-
EKG
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
WDNA vs. EKG — Risk / Return Rank
WDNA
EKG
WDNA vs. EKG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for WisdomTree BioRevolution Fund (WDNA) and First Trust Nasdaq Lux Digital Health Solutions ETF (EKG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| WDNA | EKG | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.90 | ||
| Sortino ratioReturn per unit of downside risk | +2.58 | ||
| Omega ratioGain probability vs. loss probability | 1.32 | 1.03 | +0.29 |
| Calmar ratioReturn relative to maximum drawdown | 4.34 | 0.08 | +4.26 |
| Martin ratioReturn relative to average drawdown | 9.85 | 0.18 | +9.67 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| WDNA | EKG | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.98 | 0.08 | +1.90 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.19 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.19 | -0.10 | -0.09 |
Drawdowns
WDNA vs. EKG - Drawdown Comparison
The maximum WDNA drawdown since its inception was -58.87%, which is greater than EKG's maximum drawdown of -43.82%. Use the drawdown chart below to compare losses from any high point for WDNA and EKG.
Loading charts...
Drawdown Indicators
| WDNA | EKG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -58.87% | -43.82% | -15.05% |
Max Drawdown (1Y)Largest decline over 1 year | -11.70% | -22.09% | +10.39% |
Max Drawdown (3Y)Largest decline over 3 years | -38.25% | -34.49% | -3.76% |
Max Drawdown (5Y)Largest decline over 5 years | -58.87% | — | — |
Current DrawdownCurrent decline from peak | -29.86% | -18.18% | -11.68% |
Average DrawdownAverage peak-to-trough decline | -35.64% | -22.66% | -12.98% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.14% | 9.77% | -4.63% |
Volatility
WDNA vs. EKG - Volatility Comparison
WisdomTree BioRevolution Fund (WDNA) and First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) have volatilities of 7.35% and 7.72%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| WDNA | EKG | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.35% | 7.72% | -0.37% |
Volatility (6M)Calculated over the trailing 6-month period | 16.59% | 16.76% | -0.17% |
Volatility (1Y)Calculated over the trailing 1-year period | 25.66% | 21.79% | +3.87% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 25.08% | 27.11% | -2.03% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.07% | 27.11% | -2.04% |
WDNA vs. EKG - Expense Ratio Comparison
WDNA has a 0.45% expense ratio, which is lower than EKG's 0.65% expense ratio.
Dividends
WDNA vs. EKG - Dividend Comparison
WDNA's dividend yield for the trailing twelve months is around 4.19%, while EKG has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
EKG First Trust Nasdaq Lux Digital Health Solutions ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
WDNA WisdomTree BioRevolution Fund | 4.19% | 4.57% | 0.75% | 0.80% | 0.38% | 0.10% |
Frequently Asked Questions
WDNA and EKG have a correlation of 0.62, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
EKG has higher volatility (7.72%) compared to WDNA (7.35%). In terms of maximum drawdown, WDNA dropped -58.87% vs EKG's -43.82%.
On 3-year performance, WDNA leads with 3.54% vs 0.16% for EKG. On fees, WDNA is cheaper at 0.45% per year. On volatility, WDNA has been the lower-risk option at 7.35%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 3-year period, WDNA has performed better with a 3.54% return vs 0.16%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
WDNA is cheaper with a 0.45% expense ratio, compared with 0.65% for EKG.
WDNA has the higher dividend yield at 4.19%, compared with 0.00% for EKG.
WDNA tracks WisdomTree BioRevolution Index, while EKG tracks NASDAQ Lux Health Tech Index. They also come from different issuers: WisdomTree and First Trust. Their fees differ too: 0.45% for WDNA and 0.65% for EKG.
WDNA currently has the higher Sharpe Ratio (1.98 vs 0.08), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for WDNA and EKG
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer